3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain, Postoperative
2
Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Sexual Dysfunction, Physiological
1
Pain
1
Ovarian Neoplasms
1
Mucositis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Chronic Pain
1
Anastomotic Leak
1
Agnosia
1
Acute Pain
1
Interventions
Ropivacaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Morphine
5
Acetaminophen
5
Saline Solution
4
Lidocaine
4
Ketamine
4
Fentanyl
4
Sodium Chloride
3
Dexmedetomidine
3
Bupivacaine
3
Anesthetics, Local
3
Anesthesia, Local
3
Acupuncture Therapy
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
parecoxib
2
Transcutaneous Electric Nerve Stimulation
2
Tramadol
2
Therapeutics
2
Tea
2
Surveys and Questionnaires
2
Propofol
2
Oxycodone
2
Magnesium Sulfate
2
Levobupivacaine
2
Control Groups
2
ramosetron
1
acetaminophen, codeine drug combination
1
Varenicline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Agnosia
×
Anti-Inflammatory Agents, Non-Steroidal
×
Clear all
NCT00519246
2009-03-31
COPTEAM
Nanjing Medical University
Phase 4
Completed
2,000 enrolled